首页|人工智能在肺血管疾病诊治中的研究进展

人工智能在肺血管疾病诊治中的研究进展

扫码查看
肺血管疾病(PVD)指影响肺内血管的各种疾病,主要包括肺动脉高压和肺栓塞。PVD的病理生理学和临床表现复杂,存在异质性,疾病负担严重,其诊断和治疗具有重大挑战。近年来,随着医疗信息化技术的持续发展,人工智能(AI)在疾病诊治中的应用进展迅速,为PVD的诊治提供了新的思路。现从AI在PVD中的数据来源、数据类型及临床应用等方面进行文献综述,以期为AI在PVD的早期诊断、早期治疗及规范化管理中的应用提供理论依据。
Artificial Intelligence in Diagnosis and Treatment of Pulmonary Vascular Disease
Pulmonary vascular disease(PVD)refers to a variety of diseases affecting the blood vessels in the lungs,mainly including pulmonary hypertension and pulmonary embolism.The pathophysiology and clinical manifestations of PVD are complex and heterogeneous,and the disease burden is severe,which presents a major challenge in diagnosis and treatment of PVD.In recent years,with the continuous development of medical information technology,the application of artificial intelligence(AI)in the diagnosis and treatment of diseases has progressed rapidly,providing new ideas for the diagnosis and treatment of PVD.This review provides a literature review of the data sources,data types and clinical applications of Al in PVD,with a view to providing a theoretical basis for the early diagnosis and treatment and standardized management of PVD.

Artificial intelligencePulmonary vascular diseasePulmonary hypertensionPulmonary embolism

王一佳、黄志华、高璐阳、赵智慧、赵青、罗勤、柳志红

展开 >

中国医学科学院北京协和医学院国家心血管病中心阜外医院,北京 100037

人工智能 肺血管疾病 肺动脉高压 肺栓塞

中央高水平医院临床科研业务费资助项目中国医学科学院阜外医院人工智能与信息化应用基金

2022-GSP-GG-352022-AI01

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(1)
  • 45